Apoptosis Pathway Assay (CAT#: STEM-MB-0321-WXH)

Introduction

Apoptosis is the process of programmed cell death characterized by distinct morphological characteristics and energy-dependent biochemical mechanisms. Apoptotic cells undergo morphological changes involving extensive plasma membrane blebbing followed by karyorrhexis. Apoptotic bodies are formed by separation of cell fragments during a process called "budding". Apoptotic bodies consist of cytoplasm with tightly packed organelles with or without a nuclear fragment. The organelle integrity remains enclosed within an intact plasma membrane. These bodies are subsequently phagocytosed by macrophages, parenchymal cells, or neoplastic cells and degraded within phagolysosomes. There are three main types of biochemical changes observed in apoptosis: Activation of caspases, Breakdown of DNA and protein, and Membrane changes and recognition by phagocytic cells.

Add to Cart Please Inquire

Principle Applications Procedure Materials Notes Related Products

Principle

The two most widely characterised apoptotic pathways are the Intrinsic and Extrinsic pathways.
The extrinsic signaling pathways involve transmembrane death receptors that are members of the tumor necrosis factor (TNF) receptor gene superfamily. Characterized ligands and corresponding death receptors include FasL/FasR, TNF-α/TNFR1, Apo3L/DR3, Apo2L/ DR4 and Apo2L/DR5.
The intrinsic signaling pathways that initiate apoptosis are mitochondrial-initiated events involving a diverse array of non-receptor-mediated stimuli. These stimuli cause changes in the inner mitochondrial membrane that result in an opening of the mitochondrial permeability transition (MPT) pore, loss of the mitochondrial transmembrane potential and release of two main groups of normally sequestered pro-apoptotic proteins from the intermembrane space into the cytosol. These proteins activate the caspase- dependent mitochondrial pathway. Cytochrome C binds and activates Apaf-1 as well as procaspase-9, forming an "apoptosome".

Applications

To study the regulation mechanism of apoptosis signal pathway in disease
To study the effect of each virus on apoptosis signaling pathway
To study the effects of drugs or therapies on apoptosis signaling pathways

Procedure

• Luminex Multiplex Assay
• Enzyme-linked immunosorbent assay (ELISA)
• Flow cytometry (FACS analysis) technology

Notes

Detectable targets: p53, BID, IAPs, tBID, SODD, Bad, BAK, Bax, PIDD, MYD88, Rac1, TLR4, Bcl-xl, RIP1, TRAF-2, FADD, APAF-1, BID, FADD, IRF7, Mda-5, NFκB, RIG-1, TRAF3, GAS, IRF9, MEKK1, p38, RIP1, TRAF5, Histone-H3, IRF5, MEK3, p38MAPK, SH2, TRAF6, IKK-α, IRS1, MEK6, p50, SLP76, TRAM, IKK-β, IRS2, MSK1, p65, Tak1, TRIF, IPS-1, ISGF3, MSK2, PI3K, TBK1, Vav, IRAK1, ISRE, mTOR, PKR, TLR3

Other recommended products

Diabetes Pathway Assay (CAT#: STEM-MB-0364-WXH)
NOD-like Receptor Pathway Luminex Assay (CAT#: STEM-MB-0357-WXH)
IL-13 Detection (CAT#: STEM-MB-0282-WXH)
Th17 Pathway Assay (CAT#: STEM-MB-0355-WXH)
GPCR Pathway Assay (CAT#: STEM-MB-0325-WXH)
RLRs Signaling Pathway Assay (CAT#: STEM-MB-0356-WXH)
IL-25 Detection (CAT#: STEM-MB-0292-WXH)
Vaspin Signaling Pathway Assay (CAT#: STEM-MB-0368-WXH)